FdaApplication
NDA 215429
Identifiers
- fda_app_no: NDA215429
Properties
| Property | Value |
|---|---|
| applicant_name | ALMATICA PHARMA LLC |
| application_type | NDA |
| approval_date | 2022-06-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VENLAFAXINE BESYLATE | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE;ORAL |
1 product